Research Study for Inpatient Adults with Hepatorenal Syndrome

IRB/UVA Tracking #
20248
Principal Investigator
Caldwell Stephen, H
Contact
Jennifer Greene
Contact Email
Contact Phone
434.982.2070
Official Trial Title
A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study To Confirm Efficacy And Safety Of Terlipressin In Subjects With Hepatorenal Syndrome Type 1
Study Description

The GI Hepatology department seeks adults over 18 who are inpatients with Hepatorenal syndrome (HRS), a type of kidney failure that progresses rapidly and is caused by liver failure, for a research study. The purpose of the study is to see if an investigational drug is a safe and effective treatment for HRS.

Study involves up to 14 days of IV treatment while you are an inpatient, 1 follow up visit, and two follow up phone calls. Total study participation is approximately 3 months.

Study-related medication is provided free of charge.

Compensation

$100 for completing the follow up visit